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The rearrangement ofIg genes is regulated by feedbackinhibition from Ig mole-
cules encoded by productively rearranged H and K genes (1-3). H and L genes are
activated sequentially (1). Apparently, VDJh rearrangement is halted after H chain
production(4), while the Ig gene recombinase activity persists and promotes u and
X gene rearrangement. The final shutoff ofthe recombinase seems to occur after
xrearrangement, when acomplete Ig molecule canbesynthesized (1, 5). Combina-
tion ofmembrane R (Am)1 with x is required; secreted H chains do not promote
feedback inhibition (6-8).
The regulation ofthis feedback by « seems to indicate that a J,m/u combination
acts differently than ftm alone. In the process of defining the role of the L chain
in this complex, it was necessary to determine whether X L chains would have the
same effect. In overall structure X chains are very similar to K (9). However, in the
mouse, X represents only ti5olo ofthe total serum L chains (10). Furthermore, the
regulation ofA geneexpression appears tobedifferentfromx. Ingeneral, tc-producing
B cells have rearranged tc, but maintain germline X genes. In contrast, X-producing
cells almost always have both X and u genes rearranged (11-13), and it has been sug-
gested thatXgenesmaybe activated only after failingto rearrange K genesproductively.
We report here the analysis ofIg gene expression in transgnc mice that harbor
astably integrated mouse X2 gene. Since the transcriptional enhancer forXhas not
been found (14), we replaced a portion of the JCA2 intron with the H chain en-
hancer. It was expected that this enhancer would promote transcription of the A2
transgene in early pre-B cells when H chain genes are being activated.
We chose the gene encoding X2 rather than X1 so that transgene expression could
bedistinguishedfromendogenous Xproduction. Normally, X2 is produced at a very
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low level. It represents -10-20% ofthe total X and only N1% of total L chains (10).
Furthermore, the X2 transgene carries several mutations that would, if necessary,
allow its distinction from endogenous X2.
The transgenic mice show that the X2 transgenictranscripts are found specifically
in lymphoid tissues. The presence of the X transgene decreases the expression of
endogenous L and H chain genes.
Materials and Methods
Preparation ofPlasmid a2A2H4.
￿
A 6.6-kb Eco RI genomic fragment containing the func-
tionally rearranged X2 gene of the plasmacytoma MOPC 315 (15), a gift of H. Murialdo,
University of Toronto, was subcloned into the Eco RI site of pUC19 (k2A2). The Hind III
site 14 by 3' ofJag was converted to an Nhe I site by ligation afterpartial cleavage of plasmid
k2A2 with Hind III and blunting cohesive ends with the large fragment of Escherichia coli
polymerase I (Klenow; New England Nuclear, Boston, MA). The resulting plasmid, X2A2N,
was digested partially with Xba I, completely with Nhe I, and ligated with an excess of a
997-bp Xba I genomic fragment ofthe pJ-C intron (H chain enhancer; reference 16). Clone
A2A2H4 contains the enhancer segment in the normal orientation relative to promoter se-
quences in place of 731 by of the X2 J-C intron.
Preparation ofDNA for Microinjection.
￿
Plasmid A2A2H4 was cleaved with enzymes Pvu I
and Sal l. The 7 .0-kb fragment for microinjection was isolated from 0.8% Sea Plaque (FMC
Corp., Rockland, ME) low-melting agarose gels (Fig. 1 A).
TransgenicMice.
￿
Transgenic mice were produced as described (17, 18), except that the in-
jected zygotes were from C57BL/6 mice. One transgenic line was obtained that has 8-10 copies
of the transgene presumably integrated in tandem at a single site (Fig. 1 B). The 13.4- and
3.0-kb bands are the germline CX2 and Ck3 bands, respectively. The 2.8-kb band represents
integrated transgene copies in which the Bam Hl site at the 3' end of the X2 gene has been
preserved; the 7 .0-kb band is unit length transgene spanning two neighboring copies where
the 3' Bam Hl site has been deleted. There is no band that would correspond to a junction
fragment with the host DNA, thus, apparently the 3' flanking end of the transgenes has the
Bam Hl site preserved.
Hybridomas.
￿
One 4-wk-old male transgenic mouse, 1275-4-8, was injected with 20 fig of
LPS intraperitoneally 3 d before splenectomy and fusion. This mouse was kept alivefor breeding
purposes. Hybridomas were made as previously described (7). Supernatants were tested for
Ig secretion in a modified ELISA as described by Gollahon et al. (19). L chain secretion was
detected using goat anti-mouse (GAM) L chain-specific antisera (1 :400; Southern Biotech-
nology Assoc., Birmingham, AL) as the solid-phase antibody and the assay was developed
with either peroxidase-conjugated GAMX or GAMic(1 :1,000; Southern Biotechnology Assoc.).
To determine H chain secretion, supernatants were added to plates coated with a 1 :200 dilu-
tion ofGAMW(Kirkegaard & Perry Laboratories, Gaithersburg, MD) or GAMyFc (Jackson
ImmunoResearch Laboratories, West Grove, PA) and developed with peroxidase-conjugated
GAM Ig (1 :2,000; Kirkegaard & Perry Laboratories).
NucleicAcidProcedures.
￿
DNA from hybridomas and tissues was prepared as described (20).
After digestion with restriction enzymes (New England Biolabs, Beverly, MA) the DNAs
were run on 1.0% agarose gels and blotted to Gene Screen Plus (New England Nuclear, Boston,
MA) (21). Hybridization and reprobing procedureswere as described (7). RNA preparation
and Northern blotting were as described (16).
Probes.
￿
Probes for CA and CK (22), pX2.1,Jh4, 5' ofJhl, and pDFL-2.7 (7) have been
described previously. The CX1 probe is a 158-bp Bst NI fragment isolated from pCXl (23).
The CX2 probe is a 313-bp Avr II/Pst I fragment of pXII-1 (24). The mouse tubulin 05 probe
is a 0.4-kb Bam HI fragment of pm 05 (the gift ofD. Cleveland, Princeton University; refer-
ence 25). The histone H4 probe is a 0.7-kb Bam Hl/Hind III fragment of pBRH4, a gift
of R. Grosschedl, University of California, San Francisco (26).
ELISA.
￿
The wells of 96-well half-area microtiter plates (Costar, Cambridge, MA) were
coated with 50 pl GAMFt (Kirkegaard & PerryLaboratories) or GAMy2b (Southern Biotech-
nology Assoc.) diluted 1 :200 in 0.05 M carbonate buffer, pH 9.6. The plates were incubatedHAGMAN ET AL.
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overnight at 37°C and 1olo BSA was used as a blocking agent. 25 141 of mouse serum samples
or purified mouse myeloma protein diluted in PBS containing 0.05% (vol/vol) Tween 20 (Sigma
Chemical Co., St. Louis, MO) was added and the assay then developed with 25 Al of the
appropriate anti-mouse L chain-specific reagent. Each step required a 30-min incubation
at 37oC and the plates were washed three times with PBSTween 20 between steps.
For IgM/X quantitation, biotinylated monoclonal rat anti-mouse X1 (clone R11-153.9; Phar-
Mingen, San Diego, CA) or biotinylated monoclonal rat anti-mouse X1,2 (clone R26-46;
PharMingen) diluted 1 :500 and 1 :400, respectively, in PBSTween 20 was added, followed
by 25,1/well peroxidase-labeled avidin (1 :1,000; PharMingen). Substrate (2 mM phenylene-
diamine and 0.012 % hydrogen peroxide in 24.3 mM citric acid, 51.4 mM sodium phosphate)
was then added for 5-20 min. The reaction was stopped with 57o sulfuric acid and absor-
bance detected at 490 nm. To determine Ig/K levels, the assay was developed with peroxidase-
conjugated GAMK (1 :1,000; Southern Biotechnology Assoc.) and the TMB Microwell Per-
oxidase Substrate System (Kirkegaard & Perry Laboratories) was used as substrate. The reaction
was stopped with 1 M phosphoric acid and the absorbance was detected at 450 nm. Affinity-
purified IgM/X2 (PMGII-185), IgM/X1 (MOPC-104E), and IgM/K (CH6-46.1), purchased
from PharMingen, and -y2b/K (MOPC 195/MOPC 141), purchased from ICN Biomedicals
(Naperville, IL), were used to generate the standard curves.
Flow Cytometry.
￿
Single cell suspensions of spleen cells were made and erythrocytes were
lysed with Tris-ammonium chloride. Cells were washed two times with PBS containing 1%
FCS and 0.01% sodium azide (staining buffer). Approximately 106 cells were stained with
phycoerythrin (PE)-conjugated monoclonal rat anti-mouse K (1 :50; Becton Dickinson & Co.,
Mountain View, CA), PE-conjugated GAMp (1 :100; Southern Biotechnology Assoc.), or
Fluorescein isothiocyanate-conjugated GAMX (1 :80; Southern Biotechnology Assoc.) in 100
fcl of staining buffer at 4'C. Cells were washed two times and resuspended in staining buffer
to 106 cells/ml for analysis.
Flourescence analysis was performed on an Epics V flow cytometer (Coulter Diagnostics,
Hialeah, FL) with a 5-W argon laser (Innova). Unless otherwise indicated, gating parameters
were set based on forward angle and 900 light scatter properties to exclude myeloid cells.
Two-color analysis was performed as previously described (19). Data were analyzed on an
MDADS computer interfaced with the flow cytometer.
Protein Gel Electrophoresis and Western Blotting.
￿
Mouse sera (1 Al) were fractionated by SDS-
PAGE (12% acrylamide) under reducing conditions and electroblotted to nitrocellulose as
described (7). The nitrocellulose was sequentially incubated with rabbit anti-mouse X (1 :200;
ICN Biomedicals, Costa Mesa, CA) and peroxidase-conjugated goat anti-rabbit Ig(1 :2,000;
Bio-Rad Laboratories, Richmond, CA).
Results
Tissue-specific Expression ofthe A2 Transgene.
￿
In normal mice the level of X2 expres-
sion in B cells is very low (10). Accordingly, X2 mRNA is barely detectable in the
spleens of normal mice (Fig. 2). The X2 transgenic mouse line, however, strongly
expresses X2 in the spleen and, as expected from a transgene with the H chain en-
hancer (27), in the thymus (Fig. 2). The levels of X2 in kidney and liver ofthe trans-
genic mice are higher than in normal littermates, but much lower than in spleen
and thymus. Most likely, the A2 found in these tissues derives from blood-borne B
and T cells, similar to the findings in other transgenic mice with Ig genes (22, 28).
Thus, the X2 transgene appears to be expressed in tissue-specific fashion and these
transgenic mice should be suitable as a model to study the effects of X2 expression
on Ig gene rearrangement.
Altered K/J1 Ratios on the Surface of B Cells ofA2 Transgenic Mice.
￿
To determine the
numbers of B cells producing A2 and other Igs, spleen cells were analyzed by FAGS
during the development of the mice (Table I). At all time points, the trangenic mice
had a large percentage of B cells that produced A, presumably mainly X2, ranging1914
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FIGURE 1 .
￿
The transgene . (A) MapofX2 transgene . Completely filled boxes are exons ; slashed
box is J-Cl intron segment; open box is 120 by of pUC19 . (B) Southern blot of kidney DNAs .
Digestion with Bam H1, probed with CX2 . (Lane C) C57BL/6; (lanes 1, 2, 3, 5, and 7) X1 trans-
genic mice (F2 offoundermouse); (lanes 4 and 6) normal littermates ; (lane 8) transgenic mouse
(F 1 of founder) .
from 65 to 79% ofW B cells in 4-d-old mice and decreasing to 48-56% by 70 d
ofage. On the other hand, K+ cells, which constitute at least 90% of the B cells in
normal mice, were reduced to 33-39% in 4-d-old transgenic mice . By 16d thepropor-
tion of K+ B cellshad nearly doubled in transgenic mice and had increased still fur-
ther by 10 wk . Thus, it appears that the presence of the X2 transgene reduces the
proportion of B cells expressing endogenous « genes, but that K+ B cells accumu-
late with age .
We next investigated whether the K+ B cells in transgenic mice produce X2 pro-
tein . The level of X expression in K+ cells was found to be quite low, nearly unde-
tectable by surface staining (Table 1) . That the majority of K cells may coexpress
X became evident when we examined spleen cells from mice that had been treated
with LPS intraperitoneally 3 d before the FAGS analysis (Fig . 3). As compared withHAGMAN ET AL .
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FIGURE 2.
￿
Northern blot oforganRNAs ofX2 transgenic mice (+) and normal littermates (- ) .
Each lane contained 10 ug of total cellular RNA . The blot was hybridized with a CX2 probe
(top) or a histone H4 probe (to normalize mRNA within but not between tissues) (bottom) . The
positions of mature X2 RNA and of histone RNA are indicated .
TABLE I
Fats Analysis
* + , transgenic mouse ; - , normal littermate (or normal age-matched C57BL/6 mouse -N1,
etc .) .
1 The p, K, and X values were obtained from fluorescence histograms; the K + X values were
obtained from two-color quadrant plots .
5 In brackets are the percent of total nucleated spleen cells .
II In parentheses are the percent of p+ B cells .
Age Mouse Transgenic*
Percent of lymphoid
p K
spleen
x
cells :
K +
4 d 1 + 35.51 [16.515 11 .61 (33)11 24.91 (70) 1 .91
4 + 40.7 [16 .5] 13 .3 (33) 28 .6 (70) 1 .7
6 + 29 .1 [14.31 11 .3 (39) 23 .1 (79) 1 .7
8 + 31.0 [14.4] 10 .1 (33) 23 .5 (76) 1 .9
9 + 36 .9 [15 .11 14.0 (38) 24 .1 (65) 2 .5
2 - 39 .6 118.8] 35 .5 (90) 4 .8 (12) <1
3 - 38 .7 [19.81 36.9 (95) 5 .7 (15) <1
5 - 36 .4 [18] 35.8 (98) 4 .8 (13) <1
7 - 36 .6 [21 .3] 35.4 (97) 5.6 (15) 1 .1
16 d 1 + 42 .2 [34.4] 21 .7 (51) 22 .1 (52) 2 .6
2 + 37 .8 [29.61 23.5 (62) 22.6 (60) 1 .9
3 + 41 .7 [33.41 25.5 (61) 23 .3 (56) 2 .2
5 + 39 .3 [33 .41 26.4 (67) 22.4 (57) 2 .1
7 + 36 .0 [26.7] 16.5 (46) 25 .1 (70) 2 .2
4 - 46 .1 [40.0] 50 .1 (109) 6 .6 (14) <1
6 - 56 .0 [48.1] 53 .1 (95) 8 .2 (15) <1
70 d 18 + 44 .6 [44] 26 .1 (59) 24 .8 (56) 5 .5
19 + 45 .4 [44.7] 31 .7 (70) 22 .1 (49) 5 .2
22 + 47 .4 [45.1] 31.9 (67) 22 .7 (48) 6 .8
23 - 58 .4 [561 54.4 (93) 5 .5 (9.4) <1
N1 - 52 .9 [51] 50 .1 (95) 4 .5 (9) <1
N2 - 56 .1 [53.3] 54.9 (98) 5 .2 (9) <1
N3 - 56 .3 [54.4] 51.3 (91) 5 .3 (10) <11916
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FIGURE 3 .
￿
FACS profile of4-wk-
old transgenic mouse and nor-
mal littermate . The mice had
been treated with LPS (20 Pgl
mouse, intraperitoneally) 3 d
before analysis. (Ordinate) red
fluorescence PE anti-K ; (abscis-
sa) green fluorescence FITC
anti-X .
K+ cells from normal spleen cells, there is a significant shift in the fluorescence
profile ofX expression in tc+ cells from the transgenic mice. However, the relative
fluorescence intensity ofX staining on K/X-coexpressing cells is approximately a log
lower than that seen for cells bearingX alone . The low level of X expression on a`
cells could reflect transgenic X2 expression by the respective cells or, alternatively,
binding ofcytophilic A.We favor the former interpretation, because ofobservations
made in hybridomas (see below) .
Overall, there is a slight decrease in the number of IgM+ B cells in the spleens
of the transgenic mice of all ages (Table I) .
Suppression of SerumL Chain Levels in A2 Transgenic Mice.
￿
Since X2 levels are low
in normal mice, it was possible to readily observe the increased expression of theHAGMAN ET AL.
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transgenic A2 isotype in serum Ig. In addition, X1 and X2 isotypes maybe separated
by size fractionation on SDS-PAGE. Western blots ofthe sera of 5-wk-old mice show
that the transgenic mice produce large quantities ofX2 (Fig. 4B). Notably, the level
of X1 is considerably lower than in their normal littermates, suggesting that expres-
sion of the X2 transgene suppresses the production of endogenous X chains. In 10-
wk-old mice the amount of X2 is still higher than in normal mice, and X1 still ap-
pears to be suppressed (Fig. 4 C). In very youngmice of4and 16 d ofage, the serum
L chains appear to be almost entirely of maternal origin. Offspring of anormal fe-
male show both X1 and X2, while offspring of a X2 transgenic female show mainly
A2 (Fig. 4 A) .
To obtain a more quantitative evaluation of the serum L chain levels, ELISAs
were performed (Table II). 16-d-old mice were analyzed for IgM only, due to the
preponderance of maternal IgGs. In very youngmice, V IgM is many fold higher
in transgenic mice due to X2 . At 10 wk, however, the X levels are on average only
1.5 times higher than in normal mice. A striking difference is seen when comparing
the effect of the transgene on endogenous X1 and K production. While K is reduced
to 26% of normal in newborn mice, by 10 wk the quantities of K recover to reach
56% of normal. In contrast, the level of X1 in the newborn is only reduced by one
third and becomes more depressed with age relative to normal mice, until at 10 wk
it represents as little as 3% of the normal X1 level. The quantities of total IgM are
slightly decreasedin transgenic mice of allages, in accordance with the smallreduc-
tion in surface IgM+ B cells (Table I).
Effectof112 TransgeneonS16lenic IgmRNAs.
￿
To assess the totallevel ofstable expres-
sion ofIg genes in thetransgenic mice relative to their normal littermates, Northern
blots of spleen RNA were hybridized with various Ig probes (Fig. 5). In 5-d-old
transgenic mice there is a high level of A2 mRNA, whereas in normal littermates
X2 mRNA is barely detectable (Fig. 5 A). In all mice the quantities of X2 mRNA
increase many fold with age, but the relative levels are consistently more than five
times higher in the transgenic than in the normal mice. Presumably, the dramatic
overall increase with age is mainly derived from plasma cells, since the proportion
of surface u+ cells in the spleen increases only about two- to threefold (Table I).
The amounts of K and X1 mRNA are suppressed by -50% in both newborn and
adult transgenic mice (Fig. 5, B and C), while IA mRNA appears to be only slightly
diminished in the 16-d and adult transgenic spleens and unaffected in the 5-d-old
spleens (Fig. 5 D). Interestingly, the newborn spleens of both the transgenic and
the normal mice show mainly the membrane form of juRNA, whereas in the adults
the secreted form predominates. This further supports the idea that the overall in-
crease of Ig mRNA in the adult mice is derived from plasma cells.
Tubulin mRNA was used to normalize RNA quantities in the spleen. Unexpect-
edly, tubulin mRNA in spleen decreased with age, presumably reflecting adecrease
in proliferative activity (Fig. 5 E). The relative levels are approximately the same
in transgenic mice as in their normal littermates, suggesting that the overall cellular
development is not affected by the transgene.
Hybridomasfrom112 Transgenic Mice.
￿
To determinewhetherthe suppression of en-
dogenous x and X synthesis was due to inhibition of rearrangement ofthe respective
genes, hybridomas were produced from 4-wk-old transgenic mice. We obtained a
total of 83 hybridomas representing single cell clones. Of these, 34 (41%) secreted1918
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FIGURE 4.
￿
Western blot analysis of serum X chains . (A) Sera from a litter of 16-d andtwo litters
of4-d-old mice areshown . The status of the mother is shown in parenthesis : n, normal C57BL/6
female ; t, a2 transgenic female . Within the litters the following mice were X2 transgenic (from
left to right): 16d(n) lanes 1, 3, 5, and 6 ; 4d(t) lanes 1, 2, 4, 6, and 9 ; and 4d(n) lanes 2, 4, 5,
and 6 . (B) Sera from a litter of 5-wk-old mice and (C) sera from a litter of 10-wk-old mice. T,
transgenic; N, normal littermate . Lanes 1 and2 contain 0.5 jug ofpurified myeloma proteinIgM/X1
(MOPC 104E) and IgMA2 (pmGll-185), respectively.HAGMAN ET AL.
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TABLE II
Quantitation of Serum Igs
Serum levels were quantitated in an ELISA using goat anti-mouse H chain-specific antisera as the solid
phase antibody. The assay was then developed with the appropriate anti-mouse L chain reagents as described
in Materials and Methods. T, transgenic mice; NLM, normal littermate; N, age-matched normal C57
BL/6 mouse; T/N, average of transgenic sample/average of normal sample.
Percent X1 = [X1/(X1 + X2 + X3)] x 100.
1 Percent IgMX = [(X1 + X2 + X3)/total IgM] x 100.
4 Mice T56, T57, NLM 60, and NLM 58 were LPS treated 3 d before bleeding.
Xonly; 34 (41%) secreted both X and u; 9 (11%) secreted tc only; and 6 (7%) secreted
no Ig. A subset of these was analyzed in greater detail (Table III). 39 of the 51 hy-
bridomas examined secreted X protein that was apparently derived from the trans-
genes in all but one case. The hybridoma No. 69 had deleted the transgene before
the first assay, but the cells secreted X chains due to rearrangement of endogenous
Agenes. Three otherlines (Nos. 2, 5, and 70) lost the transgenes andceased produc-
tion of X chains during culture. The 14 hybridomas that did not secrete X all had
lost the transgenes at the time of the first testing. Thus, of the hybridomas that re-
tained the transgenes, there is not a single one in which the transgene is inactive,
in striking contrast to the observations by Weaver et al. (29), that -75% of their
transgenic hybridomas did not express the w transgene.
More than half of the hybridomas (26:51; 52%) do not show any endogenous u
or X gene rearrangements. This is in contrast to normal B cells in which at least
one tc allele is rearranged (11-13), suggesting that the A2 transgene has a feedback
effect on the Ig-specific recombinase activity. In previous work with tc transgenic
IgM IgG2b
Age Mouse X1 + k2 + X3 X1 Percent X1" K Total IgM Percent V tc
Ag/ml Ag/ml % Ag/ml Ftg/ml % Ag/ml
16 d T 2 5 .4 0.19 3.5 4.9 10.3 52 ND
T 3 9.6 0.18 1 .9 5 .2 14.8 65 ND
T 5 3 .4 0.16 4.7 5 .8 9 .2 37 ND
T 7 13 .1 0.18 1 .4 6.0 19 .1 69 ND
NLM 4 <0 .4 0.22 -100 16 .8 17 .0 1 ND
NLM 6 <0 .4 0.33 -100 25 25 .3 1 ND
T/N >20 0.64 0 .26 0.63
4 wk T565 135 5 .2 4 106 241 56 168
T574 50 3 .5 7 55 105 48 62
NLM 60S 13.1 9 .9 75 109 122.1 11 218
NLM 58§ 26.5 15 .1 57 353 379.5 7 179
NLM 55 14.8 8 .8 59 74 88.8 17 104
T/N 3.9 0.39 0.45 0.88 0.69
10 wk T 18 30.4 0.55 2 80 110 28 176
T 19 38.8 0.57 2 102 141 28 310
T 22 38.8 0.57 2 79 118 33 392
NLM 23 14.2 10.2 72 97 111 13 713
N 5 27 .6 15.9 58 210 238 12 254
N 6 28.7 21 .2 74 164 193 15 618
N 7 25 .9 19 73 149 175 15 296
T/N 1 .5 0.03 0.56 0.69 0.621920
FIGURE 5 .
￿
Continued on following page.
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FIGURE 5 .
￿
Northern blots of spleen RNAs. Each lane contained 5 jig spleen RNA except the
left lane, which contained 1 Wg ofRNA ofmyelomaMOPC315(American Type Culture Collec-
tion, Rockville, MD) (*, or H12.1.1a, a X1-producing IgM transfectant ofJ558L (H), or 3'tg
ofRNAfrom LPS-induced pre-B cell line 70Z-3.12 (American Type Culture Collection) (Z) . Lanes
2-9 are from spleens of 5-d-old trangenic mice (T) or their normal littermates (N). The six lanes
on the right are pools of equal quantities ofRNA from two to eight spleens of transgenic mice
(TP) or normal littermates (NP) of 5, 16, or 70 d of age . The position of the mature form of
the respectivemRNAs is indicatedon the right. In the case ofR, themembrane (m) and secreted
(s) forms are indicated. The blots were probed with (A) CX2 ; (B) Ca; (C)CX1 ; (D) CIL ; and (E)
murine /3 5 tubulin .
mice, it was found that feedback inhibition of endogenous K gene rearrangement
only occurred in cells that produced an endogenousH chain in addition to thetrans-
genic K chain (5) . In the X2 hybridomas investigated here, 11 :26 of those that do
not show rearrangement of endogenous L chain genes do not secrete an H chain .
We presume that they lack the productive H gene allele due to chromosome loss
during or after fusion, because none show evidence of more than one H gene . 12
of the 26 hybridomas (46%) without endogenous L gene rearrangement also have
retained a germline H allele, suggesting perhaps that a complete shutoffof the Ig-
specific recombinase had occurred . Curiously, 5:20 (25%) of the hybridomas with1922
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TABLE III
Hybridomas of Spleen of 4-wk-old Transgenic Mice
K or X rearrangements also have retained a germline gene, which may suggest that
normally H gene rearrangementis ongoing at the time of K and/or Xrearrangement.
Approximately one third (19:51; 37%) of the hybridomas have rearrangments of
endogenous K genes. Five ofthesealso rearranged theirX genes. Many ofthetransgene-
containing hybridomas with endogenous Lgene rearrangement do produceH chains,
Hybridoma ELISA* Transgent K rearr§ X reard H ream
secretors
1 i + - - gi
2 i,**M ** - - VDJ
5 i** + - - gi
7 i + - - gi
12 i,[M] + - - gi
13 i + - - gi
15 i,M + - - DJ,VDJ
17 i,[G] + - - gi
27 i,G + - - gi
34 i,[G] + re V1J1,V1J3([X1]) VDJ
37 i + - - del
40 i + - - gi
42 i + retl V2J2 gi,VDJ
43 i,M + - - DJ,VDJ
45 i + del - del
48 i,M + - - DJ,VDJ
51 i + - - del
53 i,M + - - VDJ
55 i,[G] + - - gi
57 i + - - gi
59 i,M + - - DJ,VDJ
61 i,M + - - VDJ,VDJ
67 i,[G] + - - del
69 i,M - re V2J2 VDJ,VDJ
70 i** ** - - gi
73 i,[G] + - - DJ
80 i,[G] + - - del
82 i + del - DJ
86 i,M + rell V2J2 VDJ,VDJ
87 i,M + - - VDJ
Double secretors
4 d,G + re - gi,DJ
6 d,G + re, gi - gi,VDJ
33 d,G + re, gi - gi,VDJ
38 d,M + re - VDJ
56 d,M + re - VDJ
60 d,M + re - DJ,VDJ
65 d,M + re,gi - DJ,VDJ
79 d,M + re, re - gi,VDJ
continuedHAGMAN ET AL.
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Hybridomas of Spleen of 4-wk-old Transgenic Mice
Hybridomas were made from the spleen of a transgennc sibling of the mice whose FAGS
profile is shown in Figure 3; this mouse is T57 in Table II. After fusion the cells were plated
very dilute and only wells that microscopically showed a single clone were further analyzed.
[G],[M], low level y,k; ([kll), a1 protein secreted.
ELISA of the hybridoma secretions showed X(1), is and k(d), x(k), t;(M), and 'Y(G) proteins.
These were assayed as soon as cell clones were visible in the wells.
$ Presence of the y2 transgene was determined by Southern blot.
§ Rearrangement ofendogenous K genes was determined from Southern blots ofBarn Hl-digest-
ed DNA probed first with a Ca probe and after stripping reprobed with a 5' ofJKl probe
(x 2.1 ; reference 7). -, Only germline Kgenes were seen; del, K genes (or chromosome delet-
ed); re, rearranged; gl, germline.
II Rearrangement ofendogenous X genes was determined from Southern blots ofEco Rl-digested
DNA probed with a VX2 probe that crosshybridizes with Vkl (40). Vlj1, VIJ3, and V2J2
rearrangements result in 7.8-, 3.1-, and 6.5-kb fragments, respectively; -, endogenous k genes
are in germline configuration.
Rearrangement of endogenous H genes was determined from Southern blots ofDNA digested
with Barn H1 and separately with Eco R1 and probed sequentially with 5'DH and JH4. gl,
germline (unrearranged) H genes are present. In cases in which no rearrangements are seen,
we do not know ifboth alleles were unrearranged, or the other allele was lost in the hybrido-
ma, or the other allele was a VDJ rearrangement that overlaps with the restriction fragments
of the fusing line, Ag8 .653. DJ, rearrangement seen with the JH4 probe, and one to five
fragments present that hybridize with 5'DH. The fusing line does not retain DNA hybridiz-
ing with 5'DH. VDJ, rearranged band seen with J4 probe, but no hybridization with the
5'D probe. Hybridomas indicated to be VDJ/VDJ show two rearrangedJH4 bands. DJ/VDJ,
two rearranged bands with JH4, one to five bands hybridizing with 5'DH and production
of H chains. del, deletion, no evidence of H genes except in most cases the genes ofthe fus-
ing line are present.
'" These wells were originally secreting k and later became negative, apparently because of
loss of the transgenes.
1: No rearrangement visible in Southern blot, but K mRNA seen in Northern blot.
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raising the possibility that they have escaped feedback inhibition despite the pres-
ence of a complete Ig molecule.
The X2 chains encodedby thetransgene can be secreted in the absence of Hchains
as demonstrated by those lines (Nos. 37, 45, and 51) that have deleted the H genes,
but still secrete X.
Hybridoma ELISA' Transgenel K rearrs X rearrll H ream
K secretors
8 k,M - re,gi - VDJ
26 k - re,gi - del
44 k,G - re - del
49 k,M - re,gi VIJ3 VDJ
58 k,M - re,gi - VDJ
64 k,G - re - DJ
88 k,M - re,re - VDJ,VDJ
No Ig
19 - - del V2J2 del
21 - - - - del
24 - - - - gi
39 - - del - DJ
62 - - del - del
75 - - del - del
511924
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Discussion
In accordance with the previously demonstrated lymphoid cell specificity of the
H chain enhancer (27), the X2 transgeneappears to be expressed in atissue-specific
manner. Presumably, expression in the B cell lineage begins early in B cell develop-
ment when endogenous H genes become active and begin to rearrange and before
endogenous L chain loci are similarly activated. The presence of the H enhancer
is essential for proper expression, because another transgenic mouse line with the
same X2 gene without the H enhancer, but with an additional 4.0 kb 3', containing
CA4 and 1 kb 3' of CX4, did not produce significant transgenic X2 mRNA in the
spleen (unpublished observations).
The presence of the A2 transgene results in a reduction of Ig gene rearrangement
at both H and L chain loci in most cells. The effect on u genes is very similar to
that of a K transgene (5) and, presumably, results from a complete shutoff of the
Ig-specific recombinase when a productive H chain combines with the transgenic
X2. Thus, the A protein can replace K in the membrane Ig complex, which results
in feedback.
Inhibition of endogenous A production may suggest that X-producing cells are
subject to feedback inhibition of Ig gene rearrangement. This is in contrast to the
finding in K transgenic mice of normal numbers of A cells and normal quantities
of serum Aprotein (19). The suppression of X1 synthesis is more pronounced in the
X2 transgenic mice than in the K transgenic mice; it is likely that the A2 protein can
replace M in the response to many antigens where A is utilized, and thus, M cells
are not antigenically selected for expansion in the X2 transgenic mice. The protein
sequences of the V regions of X1 and X2 are 93% homologous (10) . In K transgenic
mice, on the other hand, X production from an endogenous gene may be essential.
It is noteworthy that ofthehybridomas examined, 12 % hadrearranged endogenous
A genes (Table III). This proportion is higher than expected, based on the very re-
duced number of hybridomas with K gene rearrangement. The proportion of cells
with X rearrangement is at least as high as in normal mice; there, only 3-5% of
B cells produce A (10), and since a-producing B cell lines almost never have A rear-
rangements (11-13), only -3-5% of B cellswould have X genes rearranged. Further-
more, while the serumX1, reflecting plasma cell numbers, remainsgreatly depressed
in adult mice compared with u, A1 mRNA levels recover similarlyto rc. Presumably,
B cells with nonproductive X rearrangements produce the mRNA.
Normally, spleen B cells and hybridomas derived from them have both H gene
alleles rearranged (30, 31). However, 35% of the hybridomas from the A2 transgenic
mice have a germline H allele (Table III). This presumably is due to shutoffof the
recombination process as soon as a productive H gene rearrangement results in a
A2-containing H/X Ig molecule. Similarly, germline H genes were foundin hybrid-
omas of K transgenic mice, although in a smaller proportion of the clones analyzed
(5, 7), presumably because the K transgenes underthe control ofthe K enhancer were
expressed later in B cell development than the X2 transgenes under the control of
the H chain enhancer. Based on these observations, the postulated feedback by H
chainalone on H gene rearrangement (4) must be much slower or less efficient than
the shutoffof rearrangement induced by the complete Ig molecule. The results are
compatible with the idea that H gene feedback may reduce the accessibility of V
genes for rearrangement (32), but that DJ joining would not be affected. Thus, inHAGMAN ET AL.
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pre-B cells from nontransgenicmice, DJ rearrangement may continue during Lchain
gene rearrangement, resultingin B cells in which thesecond allele is in the DJ state.
The X2 transgenic hybridomas suggest that frequently the rearrangement activity
of one H chain allele greatly lags behind that of the other, since a large proportion
have one germline H allele, while the other allele is a VDJ rearrangement (present
or presumed to be lost after cell fusion). This lagging ofrearrangementofone allele
may also occur in B cells from nontransgenic mice, but perhaps because DJ rear-
rangement continues during L chain gene rearrangement, and because the chance
for a functional I. chain gene rearrangement is smaller than that for DJ joining,
almost all B cells retain no germline H genes.
Selection of cells expressing endogenous K genes is apparently astrong modulator
of B cell distribution in the older X2 transgenic mice. Presumably, very rare cells
can be amplified by antigen-driven selection. It is apparent that the outgrowth of
K-expressing cells has occurred by as early as 2 wk after birth (Table I), at a time
when maternal Ig is still present in the pup's serum in a high concentration (Fig.
4A). The relative roles of antigen, antiidiotype responses, and other factors needs
to be determined.
There may be several ways in which cells can escape the suppression of L chain
gene rearrangement. First, the feedback by acomplete Ig molecule after productive
H gene rearrangement maynot be instantaneous. Thus, during a certain time window,
sufficient recombinasemay persist to allow L chain gene rearrangement. This period
maybe very briefin the X2 transgenic mice; if H chains are required for the activa-
tion of the L chain loci (33), then in X2 transgenic cells, the signal for L chain gene
rearrangement(H chain) and for inactivation ofthe recombinase (H chain plus X2)
would appear simultaneously. If all B cells that coexpress K and transgenic X arise
during this interval, it would require that the signal for L chain gene activation is
more efficient than that for termination of recombinase activity.
Second, K and X coexpressing cells may be members of a B cell population that
is not strictly feedback inhibitedby membrane Ig molecules during pre-B cell devel-
opment ("unregulated" lineage), such as postulated previously for X-producing cells
and Lyl B cells (19, 34, 35). A priori, those X2 transgenic hybridomas that have
germline H genes should not be derived from a feedback uninhibited B cell popula-
tion. However, allB cells seem to be recombinase negative in the mature stage (36),
and selection by antigen or antiidiotype may be the signal that inhibits the recom-
binase in the postulated unregulated B cell lineage. This signal may be generated
early in transgenic B cell development, if the particular cell is selected by antigen
or other stimuli.
Third, in certain pre-B cells thelevels of X2 protein may be toolow for a feedback
effect. Certainly, at the B cell stage there seems to be a broad range in surface X2
expression. Most of the weakly X2+ cells are also K+ (Fig. 3). It remains to be deter-
mined whether this relationship is the cause or a consequence of coexpression.
Finally, one has to consider the possibility that some pre-B cells lose the trans-
genesin the mouse due to intrachromosomal recombination (37), e.g., between sister
chromatids. This could lead to an almost complete elimination of all copies of the
transgene, e.g., if at one end of the tandem repeats a transgene fragment was in-
tegrated that could pair with a transgene copy at the otherend of the complex. The
absence of cells with a germline H gene among the transgene-negative hybridomas1926
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may suggest that this event can occur sometimes (although most often the trans-
genes are probably lost by chromosome loss in the hybridomas). Such pre-B cells
would rearrange endogenous H and L genes, like cells from normal mice.
The data presented here do not allow us to make a distinction for a given B cell
between escape from feedback inhibition during anarrow window, an unregulated
pre-B cell pool, low subthreshold transgene expression, or transgene deletion. The
finding of relatively large numbers ofcells producing endogenous L chains as early
as 4 d after birth suggests that evasion of suppression can occur independently of
antigen selection; at this early age in normal mice the expressed V gene repertoire
does not reflect selection (38).
Incomplete feedback inhibition of Ig genes in transgenic mice continues to be a
puzzle to investigators (35). The observation that is and X coexpressing B cells in-
crease with the age of X transgenic mice (this report, and M. Neuberger, personal
communication) suggests that the apparent lack of transgene effect in many cells
of transgenic mice may be due to selection and amplification of cells that have es-
caped the feedback. It would be interesting to re-examine K and H chain transgenic
mice at an earlier age.
Isotypic exclusion ofK and Xgenesis still unexplained. The inactivation of Kgenes
is not (always) required for X gene rearrangement since X-positive cells in K trans-
genic mice produce the transgenic K andsometimes, in addition, endogenous Kpro-
tein (19). As discussed above, a B cell population that is not regulated by feedback
inhibition at the pre-B stage may exist. Many ofthe endogenous Agene rearranging
cellsin the X2 (and rc) transgenic mice maybe recruitedfrom such cells. It is possible
that A gene rearrangement can also occur in the strictly regulated cell population;
K genes would have to have a much greater chance than X to be rearranged in these
cells, as originally postulated based on theobservationthat virtually allX-expressing
cellshave both is loci rearranged (11-13). Sincethe X2 transgene is under the control
of the H chain enhancer, it will be expressed very early in B cell development. In
astrictly feedback-regulated population, thetime window maybe too shortto allow
X gene rearrangement. It will be interesting to investigate the X2 mice with respect
to the cell lineages (conventional or Lyl B cells; reference 39) from which endoge-
nous A-producing cells arise.
Summary
The rearrangement of Ig genes is known to be regulated by the production of
H and a L chains. To determine whether A L chains have asimilar effect, transgenic
mice were produced with a X2 gene. It was necessary to include the H chain en-
hancer, since a X gene without the added enhancer did not result in transgene ex-
pression.
The X2 transgene with the H enhancer was expressed in lymphoid cells only. The
majority of the B cells of newborn transgenic mice produced X, whereas K+ cells
were reduced. Concomitantly, serum levels of K and K mRNA were diminished. By
2 wk afterbirththe proportion of rc-expressing cellswas dramatically increased. Adults
had reduced proportions of B cells that produced X only, but the levels of X were
still higher than in normal littermates. Also, K+ cells were still lower than in normal
mice. Analysis of hybridomas revealed that reduction of K gene rearrangement was
the basis for the decreased frequency of K+ cells. Furthermore, many cells also con-HAGMAN ET AL.
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tained an unrearranged H chain allele. It was concluded that feedback inhibition
by the X2 together with endogenous H protein may have inhibited recombinase ac-
tivity in early pre-B cells, leading to inhibition of both H chain and K gene rear-
rangement. Thus, X2 can replace K in a feedback complex.
The levels of serum X1 and, to a lesser degree, of spleen X1 mRNA were reduced
in the X2 transgenic mice. However, the proportion ofhybridomas with endogenous
X gene rearrangement was at least as high as in normal mice. It was therefore con-
cluded that the suppression of functional X1 may be a consequence ofdecreased se-
lection of endogenous X-producing cells because of the excess of transgenic A.
The escape of rc-producing cells from feedback inhibition may be the result of sev-
eral mechanisms that operate to varying degrees, among them: (a) is rearrangement
during a period in which the recombinase is still active after appearance of a X2/p,
stop signal; (b) a B cell lineage that is not feedback inhibited at the pre-B cell stage;
(c) subthreshold levels of transgenic X2 in some pre-B cells; and (d) loss of the X2
transgenes in rare pre-B cells.
We are very grateful to Karen Hagen for excellent technical assistance with flow cytometry
and to our colleagues cited in the text who have provided cloned genes.
Receivedfor publication 18 January 1989 and in revisedform 14 February 1989.
References
1 . Alt, F. W., T K. Blackwell, R. A. DePinho, M. G. Reth, and G. D. Yancopoulos. 1986.
Regulation of genome rearrangement events duringlymphocyte differentiation. Immunol.
Rev. 89:5.
2. Engler, P, and U. Storb. 1988. Immunoglobulin gene rearrangement. In Genetic Recom-
bination. R. Kucherlepati and G. Smith, editors. American Society for Microbiology,
Washington, DC. 667-700.
3. Storb, U. 1988. Immunoglobulin gene analysis in transgenic mice. In Immunoglobulin
genes. T Honjo, F. Alt, and T. Rabbits, editors. Academic Press Limited, London.
305-328.
4. Weaver, D., F. Costantini, T. Imanishi-Kari, and D. Baltimore. 1985. A transgenic im-
munoglobulin p gene prevents rearrangement of endogenous genes. Cell. 42:117.
5. Ritchie, K. A., R. L. Brinster, and U. Storb. 1984, Allelic exclusion and control of en-
dogenous immunoglobulin gene rearrangement in is transgenic mice. Nature (Lond).
312:517.
6. Nussenzweig, M. C., A. C. Shaw, E. Sinn, D. B. Danner, K. L. Holmes, H. C. Morse,
and P Leder. 1987. Allelic exclusion in transgenic mice that express the membrane form
of immunoglobulin a. Science (Wash. DC). 236:816.
7 . Manz, J. T., K. Denis, O. Witte, R. Brinster, and U. Storb. 1988. Feedback inhibition
of immunoglobulin gene rearrangement by membrane i, but not by secreted IA heavy
chains. J. Exp. Med. 168:1363.
8. Nussenzweig, M. C., A. C. Shaw, E. Sinn, J . Compos-Torres, and P Leder. 1988. Allelic
exclusion in transgenic mice carrying mutant human IgM genes. J. Exp. Med. 167:1969.
9. Kabat, E., T. T Wu, M. Reid-Miller, H. Perry, and K. Gottesman. 1988. Sequences
ofProteins ofImmunological Interest. Department ofHealth and Human Services, Public
Health Services, NIH, Bethesda, MD. 804 pp.
10 . Eisen, H. N., and E. B. Reilly. 1985. X chains and genes in inbred mice. Annu. Rev. Im-
munol. 3:337.
11 . Coleclough, C ., R. P. Perry, K. Karjalainen, and M. Weigert. 1981. Aberrant rearrange-1928
￿
X2 TRANSGENIC MICE
ments contribute significantly to the allelic exclusion of immunoglobulin gene expres-
sion. Nature (Lond.). 290:372.
12. Hieter, P. A., S. J. Korsmeyer, T. A. Waldman, and P Leder. 1981. Human immuno-
globulin K light-chain genes are deleted or rearranged in X-producing B cells. Nature(Lond).
290:368.
13. Korsmeyer, S. J., P. A. Hieter, J. V. Ravetch, D. G. Poplack, T. A. Waldmann, and P.
Leder. 1981. Development hierarchy ofimmunoglobulin gene rearrangements in human
leukemic pre-B-cells. Proc. Natl. Acad. Sci. USA. 78:7096.
14 . Picard, D., and W. Schaffner. 1984. A lymphocyte-specific enhancer in the mouse immu-
noglobulin K gene. Nature (Lond.). 307:80.
15 . Wu, G. E., N. Govindji, N. Hozumi, and H. Murialdo. 1982. Nucleotide sequence of
a chromosomal rearranged X2 immunoglobulin gene of mouse. NAR. 10:3831.
16 . Tsang, H., C . Pinkert, J. Hagman, M. E. Lostrum, R. L. Brinster, and U. Storb. 1988.
Cloning of a y 2b gene encoding anti-P, aeruginosa H chains and its introduction into
the germline. J Immunol. 141 :1:308.
17 . Brinster, R. L., H. Y. Chen, and M . E. Trumbauer. 1981. Mouse oocytes transcribe in-
jected Xenopus 5s RNA gene. Science (Wash. DC). 211:396.
18 . Brinster, R. L., H. Y. Chen, M. Trumbauer, M. K. Yagle, and R. D. Palmiter. 1985.
Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting
eggs. Proc. Natl. Acad. Sci. USA. 82:4438.
19 . Gollahon, K. A., J. Hagman, R. L. Brinster, and U. Storb. 1988. Ig X producing B cells
do not show feedback inhibition of gene rearrangement. J. Immunol. 141:2771 .
20. Wilson, R., J. Miller, and U. Storb. 1979. Rearrangement of immunoglobulin genes.
Biochemistry. 18:5013 .
21 . Southern, E. M . 1975 . Detection ofspecific sequences among DNA fragments separated
by gel electrophoresis. J Mol. Biol. 98:503.
22 . Storb, U., C. Pinkert, B. Arp, P Engler, K. A. Gollahon, J . T Manz, W. Brady, and
R. L. Brinster. 1986. Transgenic mice with 1 and K genes encoding antiphosphorylcho-
line antibodies. J Exp. Med. 164:627.
23. Miller, J ., A. Bothwell, and U. Storb. 1981. Physical linkage of the constant region genes
for immunoglobulins X1 and X3. Proc. Natl. Acad. Sci. USA. 78:3829.
24. Bothwell, A., M. Paskind, R. Schwarz, G. Sonenshein, M . Gefter, and D. Baltimore.
1981. Dual expression of X genes in the MOPC-315 plasmacytoma. Nature (Loud.). 290:65.
25. Sullivan, K. F., and D. W. Cleveland. 1986. Identification of conserved isotype-defining
variable region sequences for four vertebrate /3 tubulin polypeptide classes. Proc. Natl.
Acad. Sci. USA. 83 :4327 .
26 . Grosschedl, R., and D. Baltimore. 1985. Cell-type specificity of immunoglobulin gene
expression is regulated by at least three DNA sequence elements. Cell. 41:885 .
27 . Calame, K. L. 1985. Mechanisms that regulate immunoglobulin gene expression. Annu.
Rev. Immunol. 3 :159.
28. Brinster, R. L., K. A. Ritchie, R. E. Hammer, R. L. O'Brien, B. Arp, and U. Storb.
1983. Expression of a microinjected immunoglobulin gene in the spleen of transgenic
mice. Nature (Load.). 306:332.
29. Weaver, D., M. H. Reis, C. Albanese, F. Constantini, D. Baltimore, and T. Imanishi-
Kari. 1986. Altered repertoire of endogenous immunoglobulin gene expression in trans-
genic mice containing a rearranged 1 heavy chain gene. Cell. 45 :247.
30. Nottenburg, C., and I. L. Weissman. 1981. Cp, gene rearrangement ofmouse immuno-
globulin genes in normal B cells occurs on both the expressed and nonexpressed chromo-
somes. Proc. Natl. Acad. Sci. USA. 78:484.
31 . Iglesias, A., M. Lamers, and G. Kohler. 1987 . Expression of immunoglobulin 6 chain
causes allelic exclusion in transgenic mice. Nature (Loud.). 330:482.HAGMAN ET AL.
￿
1929
32. Yancopoulos, G. D., and F. W. Alt. 1985. Developmentally controlled and tissue-specific
expression of unrearranged V gene segments. Cell. 40:271.
33. Reth, M., E. Petrac, P. Wiese, L. Lobel, and F. W Alt. 1987. Activation of a VK gene
rearrangement in pre-B cells follows the expression of membrane-bound immunoglob-
ulin chains. EMBO (Eur Mol. Biol. Organ.) J. 6:3299.
34 . Hardy, R. R., J. L. Dangl, K. Hayakawa, G. Jager, and L. A. Herzenberg. 1986. Fre-
quent X light chain gene rearrangement and expression in a Ly-1 B lymphoma with a
productive K chain allele. Proc. Natl. Acad. Sci. USA. 83:1438.
35 . Storb, U. 1987. Transgenicmice with immunoglobulin genes. Annu. Rev. Immunol. 5:151.
36 . Lieber, M. R., J. E. Hesse, K. Mizuuchi, and M. Gellert. 1987. Developmental stage
specificity of the lymphoid V(D)J recombination activity. Genes & Dev. 1 :751.
37 . Liskay, R. M., A. Letsou, andJ. L. Stachelek. 1987. Homology requirement for efficient
gene conversion between duplicated chromosomal sequences in mammalian cells. Genetics.
115:161.
38 . Klinman, N. R., and P. J. Linton. 1988. The clonotype repertoire ofB cell subpopula-
tions. Adv. Immunol. 42:1.
39 . Hardy, R. R., and K. Hayakawa. 1986. Development and physiology of LY1 B and its
human homolog, LEU-1 B. Immunol. Rev. 93:53.
40. Miller, J., S. Ogden, M. McMullen, H. Andres, and U. Storb. 1988. The order and
orientation of mouse X genes explain X rearrangement patterns. J. Immunol. 141:2497.